| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 04/15/2010 | WO2010042886A2 Pyrone analogs for therapeutic treatment |
| 04/15/2010 | WO2010042868A2 Methods for treating obesity |
| 04/15/2010 | WO2010042682A1 Azolotriazinone melanin concentrating hormone receptor-1 antagonists |
| 04/15/2010 | WO2010042674A1 Pyrrolone melanin concentrating hormone receptor-1 antagonists |
| 04/15/2010 | WO2010042633A2 Naringenin complexes and methods of use thereof |
| 04/15/2010 | WO2010041983A1 Substituted 3-arylsulfonyl-pyrazolo[1,5-a]pyrimidines, serotonin 5-ht6 receptor antagonists and methods for the production and use thereof |
| 04/15/2010 | WO2010041748A1 Fluorene compound and use thereof for medical purposes |
| 04/15/2010 | WO2010041726A1 Substituted tricyclic heteroaryl compound |
| 04/15/2010 | WO2010041711A1 Isoquinoline derivative, and pde inhibitor comprising same as active ingredient |
| 04/15/2010 | WO2010041647A1 Physical endurance improving agent, anti-fatigue agent or fatigue recovering agent comprising amino acid composition as active ingredient |
| 04/15/2010 | WO2010041459A1 Method for quantitative analysis of drug metabolite and analyzer |
| 04/15/2010 | WO2010041410A1 Agent for suppressing increases in cholesterol |
| 04/15/2010 | WO2010041290A1 Natural molecules extracted from bergamot tissues, extraction process and pharmaceutical use |
| 04/15/2010 | WO2010041288A1 Use of l-kynurenine and derivatives thereof for the prevention and treatment of diabetes mellitus type 1 |
| 04/15/2010 | WO2010041144A2 Beta-hydroxy-gamma-aminophosphonates and methods for the preparation and use thereof |
| 04/15/2010 | WO2010041138A2 Complex between human insulin and an amphiphilic polymer, and use of said complex for preparing a quick human insulin formulation |
| 04/15/2010 | WO2010040901A1 Alternative oxidase and uses thereof |
| 04/15/2010 | WO2010040286A1 Triacetyl-3-hydroxyphenyladenosine and its use for regulating blood fat |
| 04/15/2010 | WO2010006169A3 2-methylene-19, 26-dinor-(20s, 22e, 25r)-vitamin d analogs |
| 04/15/2010 | WO2010006135A3 2-methylene-(17z)-17(20)-dehydro-19,21-dinor-vitamin d analogs |
| 04/15/2010 | WO2009125434A3 Oxime derivatives, process for their preparation, pharmaceutical composition containing the same and medicinal use thereof |
| 04/15/2010 | US20100095391 Regulation of lipid droplet formation by modulation of fit1 and fit2 and uses thereof |
| 04/15/2010 | US20100094016 Thiazoline acid derivatives |
| 04/15/2010 | US20100093861 Treatment of insulin resistance or diseases associated with insulin resistance |
| 04/15/2010 | US20100093854 Process for the preparation of (-)-(4-chloro-phenyl)-(3-trifluoromethyl-phenoxy)-acetic acid 2-acetylamino-ethyl ester |
| 04/15/2010 | US20100093853 Use of (-)(3-trihalomethylphenoxy)(4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemia |
| 04/15/2010 | US20100093852 Pharmaceutical composition comprising shikonin derivatives from lithospermum erythrorhizon for treating or preventing diabetes mellitus and the use thereof |
| 04/15/2010 | US20100093847 Anti-obesity active agent and anti-obesity method |
| 04/15/2010 | US20100093839 hypoxia-inducible factor-1 alpha (HIP-1 alpha); nucleosides, Locked Nucleic Acids; treating kidney cancer, melanoma, glioblastoma and prostate cancer, and pre-eclampsia |
| 04/15/2010 | US20100093825 Bicycloester derivative |
| 04/15/2010 | US20100093818 Benzimidazole derivatives |
| 04/15/2010 | US20100093812 Desferrithiocin polyether analogues |
| 04/15/2010 | US20100093808 Salt and polymorph of a dpp-iv inhibitor |
| 04/15/2010 | US20100093802 Ccr9 inhibitors and methods of use thereof |
| 04/15/2010 | US20100093797 Methods For Treatment Of Cognitive And Menopausal Disorders With D-Threo Methylphenidate |
| 04/15/2010 | US20100093780 Insulin resistance improving agent |
| 04/15/2010 | US20100093777 Spiro-ring compound |
| 04/15/2010 | US20100093761 Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 04/15/2010 | US20100093757 Therapeutic agents 414 |
| 04/15/2010 | US20100093755 Ketoconazole Enantiomer in Humans |
| 04/15/2010 | US20100093741 Certain chemical entities, compositions and methods |
| 04/15/2010 | US20100093728 Novel substituted bipyridine derivatives and their use as adenosine receptor ligands |
| 04/15/2010 | US20100093711 Organic compounds |
| 04/15/2010 | US20100093708 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 04/15/2010 | US20100093703 Substituted arylsulphonylglycines, the preparation thereof and the use thereof as pharmaceutical compositions |
| 04/15/2010 | US20100093692 Piperidinyl-piperidine and piperazinyl-piperidine for use in the treatment of diabetes or pain |
| 04/15/2010 | US20100093690 5-phenylthiazole derivatives and use as pi3 kinase inhibitors |
| 04/15/2010 | US20100093678 Compositions and methods of the treatment of obesity and osteoporosis |
| 04/15/2010 | US20100093672 Use of s1p receptor modulator |
| 04/15/2010 | US20100093671 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 04/15/2010 | US20100093658 Therapeutic Agent For Metabolic Syndrome and Food Containing the Therapeutic Agent |
| 04/15/2010 | US20100093657 Low glycemic mixtures |
| 04/15/2010 | US20100093654 Tetrasubstituted clucopyranosylated benzene derivatives, medicaments containing such compounds, their use and process for their manufacture |
| 04/15/2010 | US20100093632 Enamel matrix protein composition for treatment of systemic inflammatory response |
| 04/15/2010 | US20100093627 Albumin fusion proteins |
| 04/15/2010 | US20100093620 Tyrosine-rich conopeptides |
| 04/15/2010 | US20100093605 Peptides, derivatives and analogs thereof, and methods of using same |
| 04/15/2010 | US20100093604 Gpr43 and modulators thereof for the treatment of metabolic-related disorders |
| 04/15/2010 | US20100093603 Use of organic compounds |
| 04/15/2010 | US20100092610 Nutritional composition |
| 04/15/2010 | US20100092583 Antioxidant-Enriched Fruit Extracts and Uses Thereof in the Treatment and Prevention of Diabetes and Obesity |
| 04/15/2010 | US20100092580 Weight Reducing Composition |
| 04/15/2010 | US20100092569 Product based on conjugated linoleic acid and a method for the manufacture thereof |
| 04/15/2010 | US20100092551 Solid preparation comprising alogliptin and pioglitazone |
| 04/15/2010 | US20100092545 Polyethylene-oxide based films and drug delivery systems made therefrom |
| 04/15/2010 | US20100092486 Modulation of myeloid differentation primary response gene 88 (myd88) expression by antisense oligonucleotides |
| 04/15/2010 | US20100092462 Methods for Suppressing Toll-Like Receptor Activity |
| 04/15/2010 | US20100092449 Treatment of Pompe's Disease |
| 04/15/2010 | US20100092445 Adoptive immune cells for tumor vaccines |
| 04/15/2010 | US20100092441 Use of nitrites and nitrates and compositions containing these |
| 04/15/2010 | US20100092436 Compositions and methods for restoring immune responsiveness in patients with immunological defects |
| 04/15/2010 | US20100092433 Vascularized islets and methods of producing same |
| 04/15/2010 | US20100092422 Poly (ß-hydroxy short-medium chain fatty acid) |
| 04/15/2010 | CA2755968A1 Substituted 3-arylsulfonyl-pyrazolo[1,5-a]pyrimidines, serotonin 5-ht6 receptor antagonists and methods for the production and use thereof |
| 04/15/2010 | CA2740003A1 Pyrone analogs for therapeutic treatment |
| 04/15/2010 | CA2739787A1 .beta.-hydroxy-.gamma.-aminophosphonates and methods for the preparation and use thereof |
| 04/14/2010 | EP2174955A1 Ifnar2 muteins, their production and use |
| 04/14/2010 | EP2174954A1 Hematopoietic cell e-selection/l-selectin ligand polypeptides and methods of use thereof |
| 04/14/2010 | EP2174945A1 Antisense modulation of apolipoprotein B expression |
| 04/14/2010 | EP2174659A1 Substituted indeno[1,2-c]isoquinoline derivatives and uses thereof |
| 04/14/2010 | EP2173876A2 T-cell cytokine-inducing surface molecules and methods of use |
| 04/14/2010 | EP2173750A1 Spirocycles as inhibitors of 11-beta hydroxyl steroid dehydrogenase type 1 |
| 04/14/2010 | EP2173737A1 Method for modulating gpr119 g protein-coupled receptor and selected compounds |
| 04/14/2010 | EP2173717A2 Novel glucokinase activators and methods of using same |
| 04/14/2010 | EP2173711A1 Phenoxy-pyrrolidine derivative and its use and compositions |
| 04/14/2010 | EP2173174A1 Farnesoid x receptor agonists |
| 04/14/2010 | EP1919869B1 Indole derivatives as ppar activators |
| 04/14/2010 | EP1537078B1 Indoles having anti-diabetic activity |
| 04/14/2010 | EP1477482B1 Novel phenylalanine derivative |
| 04/14/2010 | EP1363636B1 A combination comprising levosimendan and a calcium source for the treatment of heart failure |
| 04/14/2010 | CN1985915B Chinese medicine for treating diabetes complicated peripheral neuropathy |
| 04/14/2010 | CN1927383B Compound recipe preparation for lowering oxidative stress rapidly and preparation method therefor |
| 04/14/2010 | CN1907357B Compound recipe pollen extract oral liquid for regulating blood pressure and blood fat, and process for preparing same |
| 04/14/2010 | CN1778296B Long-acting preparation for tatin medicine |
| 04/14/2010 | CN101694487A Screening method, extracting method, content measuring method and application of glycyrrhisoflavone in liquorice |
| 04/14/2010 | CN101693736A Novel peptides |
| 04/14/2010 | CN101693730A Mangiferin and preparation method and application thereof |
| 04/14/2010 | CN101693697A Pyrizdazine derivatives and their use as therapeutic agents |
| 04/14/2010 | CN101693108A Oral nutrition composition for beautifying skin |
| 04/14/2010 | CN101693104A New application of thymic peptide-5 |